DGAP-News: VYTERIS, INC. ANNOUNCES LIDOSITE(R) MARKETING AGREEMENT WITH LABCORP(R) (wallstreet:online AG)
Release of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer / publisher is solely responsible for the content of this announcement.

Vyteris, Inc. Announces LidoSite(R) Marketing Agreement with LabCorp(R) (Business Wire via Yahoo! Finance)
FAIR LAWN, N.J.----Vyteris, Inc. today announced an agreement granting Laboratory Corporation of America Holdings , a national leader in clinical laboratory testing, rights to represent and offer Vyteris' LidoSite , the first FDA-approved active transdermal smart patch for relief from pain associated with venipunctures and blood draws among certain patients.

FDA Grants Ceragenix's Request for Designation (Business Wire via Yahoo! Finance)
DENVER----Ceragenix Pharmaceuticals, Inc. , a biopharmaceutical company focused on infectious disease and dermatology, today announced that the FDA's Office of Combination Products, in response to a formal request, has determined that the primary mode of action for an antimicrobial wound dressing that is currently being developed by the Company is that of a device and it has been assigned to the ...